Sandler Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Sandler Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100,000	Closed	-$7.36M	–	114
2016 Q2	$7.36M	Buy	+100,000	New	+$7.07M	0.97%	38
2014 Q1	–	Sell	-346,700	Closed	-$18.4M	–	181
2013 Q4	$18.4M	Buy	+346,700	New	+$17.7M	0.6%	52

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sandler Capital Management's BMY Position: Q3 2016 in Review

Sandler Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 100,000 shares — an estimated $7.36M sold.

Sandler Capital Management first reported a position in BMY in Q4 2013 and held it in 2 quarters. The position peaked at $18.4M in Q4 2013. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Sandler Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
Sandler Capital Management sold 100,000 Bristol-Myers Squibb shares in Q3 2016, an estimated $7.36M.
Sandler Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 2 quarters.
Sandler Capital Management's Bristol-Myers Squibb position peaked at $18.4M in Q4 2013.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Sandler Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.